A randomized, multicenter, open-label phase III trial of hyperthermic intraperitoneal chemotherapy in platinum-resistant recurrent ovarian cancer (KOV-HIPEC-02). This is an ASCO Meeting Abstract from ...
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial Earlier detection of cancer offers an opportunity to ...
The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...
PBFT02 administration resulted in improvements in two disease progression biomarkers, as compared to natural history, reducing brain atrophy and ...
Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on precision medicines for neuropsychiatric disorders, today announced the initiation of a Phase 2b randomized, ...
Elemento is the director of the Englander Institute for Precision Medicine at Weill Cornell Medicine. Sternberg is the clinical director of the Englander Institute for Precision Medicine. Khozin is ...
Passage Bio initiated a strategic review process after regulators didn't support a single-arm trial design for its dementia drug. The Food and Drug Administration indicated a randomized controlled ...
A randomized controlled trial in Turkey found that high school students given unrestricted access to generative AI for math practice performed worse on later independent exams than peers without AI ...
A randomized controlled trial in Knox County Schools found that early elementary students receiving tutoring aligned with their core reading curriculum made the equivalent of 1.3 additional months of ...
In dementia care relying only on randomized controlled trials can leave out a large amount of strong research that reflects ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results